Geoffrey M. Ossias is a member of the firm's Corporate Services Group and co-chairs the firm’s Emerging Growth Companies practice.
Mr. Ossias focuses on emerging technology companies in the IT, life sciences, renewable energy, real estate and financial services sectors. He regularly represents issuers and institutional investors in connection with a wide variety of strategic transactions, including debt and equity financings, M&A transactions, executive employment contracts and equity incentive plans, development, sales and marketing agreements, JVs, manufacturing, distribution, license and supply arrangements, restructurings and the resolution of complex corporate governance matters.
Prior to joining Quarles, Mr. Ossias was counsel with a premier Silicon Valley emerging growth firm, Cooley, LLP. And prior to beginning his private practice, Mr. Ossias was Senior Counsel with the Securities and Exchange Commission’s Division of Corporation Finance in Washington, D.C.
Mr. Ossias also brings to his practice significant business-side experience as one of the co-founders of MyPoints.com, a publicly traded (Nasdaq: MYPT) Internet marketing firm based in San Francisco and acquired by an affiliate of United Airlines in 2001. As MyPoints' senior executive responsible for corporate development and investor relations, Mr. Ossias oversaw strategic partnerships and the company’s initial and follow-on offerings raising more than $200 million.
Mr. Ossias sits on the Board of Directors of the Arizona Technology Investor Forum, the leading angel investor group serving startups in the Phoenix area, and Seed Spot, a Phoenix-based incubator.
A representative selection of Mr. Ossias’ transactional experience* includes:
- Regularly represent Dignity Health in connection with new venture investments.
- Regularly represent Canal Partners, a leading Arizona-based private equity group, in connection with new venture investments.
- Represented ATIF Sidecar Fund I and Fund II in connection their formation and certain investments.
- Represent Blue Ventures, a venture fund established by the State of Hawaii to invest in early-stage technology companies.
- Represent BioAccel, a leading "philanthrocapitalist" focused on Arizona-based life sciences companies.
- Represented a leading provider of low-energy lighting solutions in private placements of convertible debt and equity raising more than $10 million.
- Represented Limos.com in connection with a $10 million investment by Austin Ventures.
- Represented a leading for-profit educator in connection with a strategic investment in a technology provider.
- Represented a California-based life sciences company in connection with its $12 million financing led by a prominent VC fund.
- Represented a Bay Area Internet company in connection with its $3.5 million credit line provided by a leading venture bank.
- Represented a Bay Area SaaS company in connection with its convertible note offering led by 500 Startups.
- Represented a leading cancer drug developer in connection with its $335 million cash sale to a major pharmaceutical firm.
- Represented Essex Woodlands Health Ventures in connection with its lead participation in a $40 million Series B investment in Millennium Pharmacy Systems.
- Represented Metastatix in connection with its $35 million Series B round led by Frazier Healthcare Ventures.
- Represented Menlo Ventures in connection with its lead participation in the $28 million Series B issuance by nComputing.
- Represented DuPont Fabros Technology, a major developer of wholesale data centers, in connection with its $740 million IPO.
* Some transactions handled prior to joining Quarles & Brady.